SCHEMBL1013637

SCHEMBL1013637

CN(CC(C)(N)c1cc(F)cc(F)c1)C1(C(=O)O)CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.34
CTSD P07339 8/20 0.34
BACE1 P56817 8/20 0.34
HSD11B1 P28845 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1012605 0.99 RIPK1 (0.34) RIPK1CTSDBACE1
SCHEMBL1014016 0.78 CTSD (0.35) RIPK1CTSDBACE1
SCHEMBL4192601 0.76 CTSD (0.37) CTSDBACE1CYP3A4
SCHEMBL1225573 0.72 DRD2 (0.36) RIPK1HSD11B1
SCHEMBL16704779 0.71 CYP2C19 (0.31)
SCHEMBL977079 0.69 BACE1 (0.36) CTSDBACE1CYP3A4
SCHEMBL981358 0.68 OPRL1 (0.35) CTSDBACE1
SCHEMBL2089260 0.64 CYP2C19 (0.38)
SCHEMBL10207189 0.63 CYP2C19 (0.34)
SCHEMBL1786646 0.62 CTSD (0.42) RIPK1CTSDBACE1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2271346-A2 MONOCYCLIC CGRP RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2011-01-12 EP disclosed
WO-2009120652-A2 MONOCYCLIC CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2009-10-01 WO disclosed
EP-2029575-A1 SUBSTITUTED SPIROCYCLIC CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2009-03-04 EP disclosed
WO-2008020902-A1 SUBSTITUTED SPIROCYCLIC CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2008-02-21 WO disclosed